Andre Thierry, MD on Phase 3 KEYNOTE-177: Future Treatment @UPMC #ASCO2020

Andre Thierry, MD on Phase 3 KEYNOTE-177: Future Treatment @UPMC #ASCO2020

User Photo
Cancer-News

1 month
9 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Andre Thierry, MD of University Pierre et Marie Curie @UPMC discusses pembrolizumab vs. chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: the phase 3 KEYNOTE-177 study presented at this year's virtual ASCO.

Read here: https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.18_suppl.LBA4

Up Next Autoplay
User Photo